All Stories

  1. The Dynamic Nature of Caregiving in Advanced Heart Failure With Left Ventricular Assist Device Support: A Systematic Review and Thematic Synthesis
  2. Feasibility of a heart failure management programme using Remote Dielectric Sensing technology for the non-invasive lung fluid monitoring in primary care: A mixed-methods study
  3. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
  4. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
  5. Describing the use of remote dielectric sensing and handheld ultrasound in assessing lung congestion in heart failure patients within a primary care setting
  6. Effects of exergaming and yoga on exercise capacity and physical and mental health in heart failure patients: a randomized sub-study
  7. Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study
  8. Successful use of point-of-care ultrasound for an elderly patient with heart failure in a primary care setting: a case report
  9. Fluid Restriction for Patients with Heart Failure: Current Evidence and Future Perspectives
  10. Why should a national cardiology society affiliate with the Association of Cardiovascular Nursing and Allied Professions?
  11. Changes over time in patient‐reported outcomes in patients with heart failure
  12. Psychometric properties of the Japanese version of the Self-Care of Heart Failure Index version 7.2
  13. Adaptación cultural del Cuestionario de autocuidado en pacientes con asistencia ventricular definitiva
  14. Validity and reliability of the left ventricular assist device self-care behaviour scale
  15. Globe is Still Heterogenous from the Perspective of Heart Failure
  16. Factors associated with lack of improvement in submaximal exercise capacity of patients with heart failure
  17. Methodological quality of studies assessing validity and reliability of the European Heart Failure Self-care Behaviour Scale: a systematic review using the COSMIN methodology
  18. The consequences of the COVID‐19 pandemic for self‐care in patients supported with a left ventricular assist device
  19. Trajectory of self-care behaviour in patients with heart failure: the impact on clinical outcomes and influencing factors
  20. Psychometric Testing of the Hebrew Version of the European Heart Failure Self-Care Behaviour Scale
  21. Development of an Instrument for Measuring Self-Care Behaviors After Left Ventricular Assist Device Implantation
  22. Thirst in Patients With Heart Failure in Sweden, the Netherlands, and Japan
  23. Quality of life of family caregivers of patients with a left ventricular assist device in Japan
  24. Development and psychometric evaluation of the Thirst Distress Scale for patients with heart failure
  25. Health literacy is independently associated with self-care behavior in patients with heart failure
  26. How effective is an in-hospital heart failure self-care program in a Japanese setting? Lessons from a randomized controlled pilot study
  27. Development and Validation of a Heart Failure–Specific Health Literacy Scale
  28. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy
  29. Heart Failure Telemonitoring in Japan and Sweden: A Cross-Sectional Survey
  30. Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device
  31. Corrigendum to “Differential impacts of achieved heart rate and achieved dose of β-blocker on clinical outcomes in heart failure with and without atrial fibrillation”[Int. J. Cardiol. 173 (2) (2014) 331–3]
  32. Learning Self-care After Left Ventricular Assist Device Implantation
  33. Differential impacts of achieved heart rate and achieved dose of β-blocker on clinical outcomes in heart failure with and without atrial fibrillation
  34. Impact of Comorbidities on Economic and Health Outcomes for Patients With Cardiovascular Disease
  35. Late-Onset Right Ventricular Failure in Patients With Preoperative Small Left Ventricle After Implantation of Continuous Flow Left Ventricular Assist Device
  36. Urine Sodium Excretion After Tolvaptan Administration Is Dependent Upon Baseline Serum Sodium Levels
  37. A Randomized Controlled Pilot Study of the Japanese Heart Failure Self-Management Program: Impacts on Heart Failure Knowledge and Clinical Outcomes
  38. Is Achieved Heart Rate a Surrogate Maker during Titration of Beta-blocker in Heart Failure with Atrial Fibrillation?
  39. Psychometric Testing of the Japanese Version of the Self-Care of Heart Failure Index
  40. Comparison of self-care behaviors of heart failure patients in 15 countries worldwide
  41. Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation
  42. A Case With Recovery of Response to Tolvaptan Associated With Remission of Acute Kidney Injury and Increased Urine Osmolality
  43. Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
  44. Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
  45. Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation
  46. Successful Treatment of Hemodynamic Compromise Caused by Antibody-Mediated and Cellular Rejection in a Recipient 12 years After Heart Transplantation
  47. Trend of Clinical Outcome and Surrogate Markers During Titration of ^|^beta;-Blocker in Heart Failure Patients With Reduced Ejection Fraction
  48. Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
  49. An elevated ratio of early to late diastolic filling velocity recovers after heart transplantation in a time-dependent manner
  50. Quality of Life as a Surrogate Marker to Predict Cardiac Events in Heart Failure with Reduced and Preserved Ejection Fraction
  51. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device
  52. How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?
  53. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction
  54. Development of self-care educational material for patients with heart failure in Japan: a pilot study
  55. Combination Evaluation of Preoperative Risk Indices Predicts Requirement of Biventricular Assist Device
  56. Novel Risk Scoring System With Preoperative Objective Parameters Gives a Good Prediction of 1-Year Mortality in Patients With a Left Ventricular Assist Device
  57. Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient
  58. Symptom-Monitoring and Treatment-Seeking Behaviors in Japanese Patients with Heart Failure: A Multicenter Study
  59. Translation and Validation Study of the Japanese Versions of the Coronary Revascularisation Outcome Questionnaire (CROQ-J)
  60. Age and Preoperative Total Bilirubin Level Can Stratify Prognosis After Extracorporeal Pulsatile Left Ventricular Assist Device Implantation
  61. Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 Diabetes
  62. Less Frequent Opening of the Aortic Valve and a Continuous Flow Pump Are Risk Factors for Postoperative Onset of Aortic Insufficiency in Patients With a Left Ventricular Assist Device
  63. Quality of Life as an Independent Predictor for Cardiac Events and Death in Patients With Heart Failure
  64. Could Pimobendan Improve Clinical Outcomes of Patients With Chronic Heart Failure?
  65. Validity and Reliability of Seattle Angina Questionnaire Japanese Version in Patients With Coronary Artery Disease
  66. Relationship of Depressive Symptoms With Hospitalization and Death in Japanese Patients With Heart Failure
  67. Adherence to self-care behavior and factors related to this behavior among patients with heart failure in Japan
  68. Carvedilol Improves Clinical Outcomes in Heart Failure With Preserved Ejection Fraction (HFpEF) as Well as Reduced Ejection Fraction (HFrEF)
  69. Importance of Enhancing Self-Care Behavior in Patients With Chronic Heart Failure to Prevent Re-hospitalization for Worsening Heart Failure
  70. Preventive advice given by patients with type 2 diabetes to their offspring
  71. Validity and Reliability of the Japanese Version of the European Heart Failure Self-Care Behavior Scale
  72. Depression is an independent predictor of hospitalization in outpatients with heart failure
  73. Factors Associated with Self-Care Behavior of Heart Failure Patients Assessed with the European Heart Failure Self-Care Behavior Scale Japanese Version